Asked about the FDA's warning about the use of hydroxychloroquine for coronavirus patients, Trump responded by attacking a non-peer reviewed study released last month that found an increased risk of death associated with patients who were only treated with the antimalarial drug — calling it a "false study."

Why it matters: The president, who revealed Monday he is taking the drug as a "line of defense" against the virus, referred to the study as a "Trump enemy statement." He did not address the FDA's warning that hydroxychloroquine appears to cause some serious and potentially life-threatening side effects in coronavirus patients.

Context: The study in question was not peer reviewed and retrospectively analyzed a very small pool of male veterans, with approval from Veterans Affairs.

  • The authors of the study stressed that their limited findings "highlight the importance of awaiting the results of ongoing prospective, randomized, controlled studies before widespread adoption of these drugs."

What they're saying: "No, that's not what I was told," Trump said in response to a question about the FDA warning. "There was a false study done where they gave it to very sick people, extremely sick people, people that were ready to die. It was given by obviously not friends of the administration, and the study came out, the people were ready to die, everybody was old, had bad problems with hearts, diabetes and everything else you can imagine."

  • Veterans Affairs Secretary Robert Wilkie weighed in after and said, "That was not a VA study. Researchers took VA numbers and they did not clinically review them, they were not peer reviewed. They did not even look at what the president just mentioned — the various co-morbidities that the patients who were referenced in that study had."
  • He continued: "So I want to knock down the phony story that this is somehow the VA going back on what the president told us to do, which was to use every means possible to protect and preserve the lives of our veterans."

Go deeper: Stunned Fox News host reacts to Trump taking hydroxychloroquine

Go deeper

Aug 26, 2020 - Health

Carson: It would "behoove" us to move forward with COVID-19 vaccine and treatment testing

Screenshot: Axios Events

Housing and Urban Development Secretary Ben Carson says "this is not necessarily the time to take everything slowly" when it comes to the Trump administration's approach to getting vaccines and treatments to the public.

Why it matters: Carson's comments, made Wednesday during an Axios virtual event, came days after the Food and Drug Administration announced an emergency use authorization (EUA) for treating the coronavirus with convalescent plasma. President Trump accused the agency of slow-walking the development and approval of vaccines and therapeutics to hurt him politically.

FDA authorizes Abbott's $5 rapid COVID-19 test

Results from the BinaxNOW COVID-19 Ag Card test will be available in roughly 15 minutes. Photo: Courtesy of Abbott Laboratories.

Abbott Laboratories said Wednesday it received emergency use authorization (EAU) from the Food and Drug Administration for its COVID-19 test that works without lab equipment.

The big picture: Abbott said it will ramp up production of its "highly portable," $5 tests to 50 million by the beginning of October.

Coronavirus cases fell by 15% this week

Expand chart
Data: The COVID Tracking Project, state health departments; Map: Andrew Witherspoon, Sara Wise/Axios

New coronavirus infections fell by almost 15% over the past week, continuing a steady downward trend.

Why it matters: The standard caveats still apply — progress can always fall apart, the U.S. is climbing down from a very high number of cases, and this is far from over. But this is undeniably good news. Things are getting better.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!